Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works very well agains… Read More

Adar Poonawalla, Chief Executive Officer of Serum Institute of India, has stated that their Covovax vaccine would be approved as a booster dosage against Covid-19 within the next 10 to 15 da… Read More

New Delhi: Amid rising coronavirus cases, the Serum Institute of India has written a letter to the Union health ministry seeking the inclusion of its Covid-19 vaccine Covovax on the CoWIN po… Read More

Salem: Amidst a threat of rising COVID cases in the country, a special COVID-19 ward with 500 beds was set up at Salem Government Mohan Kumaramangalam Medical College and Hospital by the dis… Read More

New Delhi: The Union Health Ministry has held a meeting with domestic and international pharmaceutical companies for the introduction of human papillomavirus (HPV) vaccine against cervica… Read More

            The Economic Times Awards for Corporate Excellence Jury is now being presented. Synopsis  Meet The Economic Times Awards for Cor… Read More

Natasha Poonawalla, the wife of Adar Poonawalla, CEO of Serum Institute of India (SII), recently took to Instagram to share photos of herself dressed in a red and white puffer coat couture g… Read More

Pune’s Contribution to COVID 19 Vaccine Development The regular time period that it takes for the development of a vaccine is 10-15 years, but when… Read More

Amid the rising monkeypox scare, Serum Institute of India (SII) CEO Adar Poonawalla said on Tuesday they are in talks with American biotech company Novavax to develop a messenger RNA (mRNA)… Read More

The list of 500 most valuable private companies in India has been refreshed by Axis Bank’s Burgundy Private and Hurun India. The Burgundy Private Hurun India 500 l… Read More

Synopsis Addressing the annual general meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) virtually on Thursday, he flagged the issue of inequities in access to COVID… Read More

The Serum Institute of India will attempt to launch an Omicron-specific vaccine for COVID-19 after six months, Adar Poonawalla, CEO of SII said on Thursday. Talking to reporters on the sidel… Read More

Monkeypox arrival in India: Serum Institute to import vaccine India is seeing rising cases of Monkeypox in the last few days, amid this foreseeing emergency Adar Poonawalla, CEO of Serum… Read More

Billions need to be vaccinated at a faster rate to reach the end of the COVID-19 pandemic, said Adar Poonawalla, CEO of the Serum Institute of India (SII), which manufactures the COVID-19 va… Read More

सीरम इंस्टीट्यूट ऑफ इंडिया (SII) के CEO… Read More

Corona Booster Dose: सीरम इंस्टीट्यूट ऑफ इंडिया (SII… Read More